- Joined
- Mar 4, 2015
- Messages
- 50,190
- Reaction score
- 10,419
Vaccine effectiveness against Omicron: study
After showing the safety and effectiveness of the single-dose Johnson & Johnson Ad26.COV2.S Covid-19 vaccine in two studies, the Sisonke team published one of the first real-world studies on vaccine effectiveness against the Omicron variant in the New England Journal of Medicine on 4 May 2022.
After showing the safety and effectiveness of the single-dose Johnson & Johnson Ad26.COV2.S Covid-19 vaccine in two studies, the Sisonke team published one of the first real-world studies on vaccine effectiveness against the Omicron variant in the New England Journal of Medicine on 4 May 2022.